These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 22680626)

  • 1. Pathophysiological roles of transglutaminase - catalyzed reactions in the pathogenesis of human diseases.
    Martin A; De Vivo G; Iannaccone M; Stefanile A; Serretiello E; Gentile V
    Inflamm Allergy Drug Targets; 2012 Aug; 11(4):278-84. PubMed ID: 22680626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of transglutaminase-catalyzed reactions in the post-translational modifications of proteins responsible for immunological disorders.
    De Vivo G; Martin A; Trotta T; Gentile V
    Inflamm Allergy Drug Targets; 2008 Mar; 7(1):24-9. PubMed ID: 18473897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the transglutaminase enzymes in the nervous system and their possible involvement in neurodegenerative diseases.
    De Vivo G; Di Lorenzo R; Ricotta M; Gentile V
    Curr Med Chem; 2009; 16(36):4767-73. PubMed ID: 19929789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue transglutaminase and coeliac disease pathogenesis: potential molecular mechanisms for other human diseases.
    Gentile V; Violante V; D'Amico B; Illiano M; Luongo A
    Neurochem Int; 2002 Jan; 40(1):79-83. PubMed ID: 11738474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms responsible for the involvement of tissue transglutaminase in human diseases: Celiac Disease.
    Amantea G; Cammarano M; Zefferino L; Martin A; Romito G; Piccirillo M; Gentile V
    Front Biosci; 2006 Jan; 11():249-55. PubMed ID: 16146729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transglutaminase-catalyzed reactions responsible for the pathogenesis of celiac disease and neurodegenerative diseases: from basic biochemistry to clinic.
    Martin A; Romito G; Pepe I; De Vivo G; Merola MR; Limatola A; Gentile V
    Curr Med Chem; 2006; 13(16):1895-902. PubMed ID: 16842200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transglutaminase-catalyzed post-translational modifications of proteins in the nervous system and their possible involvement in neurodegenerative diseases.
    De Vivo G; Gentile V
    CNS Neurol Disord Drug Targets; 2008 Oct; 7(4):370-5. PubMed ID: 18991665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physio-pathological roles of transglutaminase-catalyzed reactions.
    Ricotta M; Iannuzzi M; Vivo GD; Gentile V
    World J Biol Chem; 2010 May; 1(5):181-7. PubMed ID: 21541002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidences for a role of protein cross-links in transglutaminase-related disease.
    Tabolacci C; Lentini A; Provenzano B; Beninati S
    Amino Acids; 2012 Feb; 42(2-3):975-86. PubMed ID: 21800260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminases as possible therapeutic targets in neurodegenerative diseases.
    Martin A; De Vivo G; Ricotta M; Iannuzzi M; Gentile V
    Recent Pat CNS Drug Discov; 2010 Nov; 5(3):195-202. PubMed ID: 20636272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transglutaminase inhibition as a possible therapeutical approach to protect cells from death in neurodegenerative diseases.
    Iannaccone M; Serretiello E; De Vivo G; Martin A; Stefanile A; Titta F; Gentile V
    Recent Pat CNS Drug Discov; 2013 Aug; 8(2):161-8. PubMed ID: 23688272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deamidation and cross-linking of gliadin peptides by transglutaminases and the relation to celiac disease.
    Skovbjerg H; Koch C; Anthonsen D; Sjöström H
    Biochim Biophys Acta; 2004 Nov; 1690(3):220-30. PubMed ID: 15511629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible physiopathological effects of the transglutaminase activity on the molecular mechanisms responsible for human neurodegenerative diseases.
    Iannaccone M; Titta F; Serretiello E; Monfregola M; Gentile V
    Recent Pat CNS Drug Discov; 2014; 9(2):76-84. PubMed ID: 25386917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 2 in celiac disease: minireview article.
    Caputo I; D'Amato A; Troncone R; Auricchio S; Esposito C
    Amino Acids; 2004 Jul; 26(4):381-6. PubMed ID: 15290344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gliadin is a good substrate of several transglutaminases: possible implication in the pathogenesis of coeliac disease.
    Skovbjerg H; Norén O; Anthonsen D; Moller J; Sjöström H
    Scand J Gastroenterol; 2002 Jul; 37(7):812-7. PubMed ID: 12190095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible physiopathological roles of the transglutaminase activity in the etiopathogenesis of human neurodegenerative diseases.
    Titta F; Iannaccone M; Martin A; Gentile V
    Recent Pat CNS Drug Discov; 2014; 9(2):101-9. PubMed ID: 24924102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transglutaminase-dependent formation of protein aggregates as possible biochemical mechanism for polyglutamine diseases.
    Violante V; Luongo A; Pepe I; Annunziata S; Gentile V
    Brain Res Bull; 2001 Oct-Nov 1; 56(3-4):169-72. PubMed ID: 11719247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transglutaminase activity as a possible therapeutical target in neurodegenerative diseases.
    Iannaccone M; Titta F; Serretiello E; De Vivo G; Martin A; Gentile V
    Recent Pat CNS Drug Discov; 2013 Dec; 8(3):235-42. PubMed ID: 24286449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical mechanisms for a possible involvement of the transglutaminase activity in the pathogenesis of the polyglutamine diseases: minireview article.
    Pepe I; Occhino E; Cella G; Luongo A; Guardascione F; Gentile V
    Amino Acids; 2004 Jul; 26(4):431-4. PubMed ID: 15290350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transglutaminase 2-targeted autoantibodies in celiac disease: Pathogenetic players in addition to diagnostic tools?
    Lindfors K; Mäki M; Kaukinen K
    Autoimmun Rev; 2010 Sep; 9(11):744-9. PubMed ID: 20547248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.